200 related articles for article (PubMed ID: 24305621)
1. C-reactive protein, APOE genotype and longitudinal cognitive change in an older population.
Lima TA; Adler AL; Minett T; Matthews FE; Brayne C; Marioni RE;
Age Ageing; 2014 Mar; 43(2):289-92. PubMed ID: 24305621
[TBL] [Abstract][Full Text] [Related]
2. Trajectories of inflammatory markers and cognitive decline over 10 years.
Metti AL; Yaffe K; Boudreau RM; Simonsick EM; Carnahan RM; Satterfield S; Harris TB; Ayonayon HN; Rosano C; Cauley JA;
Neurobiol Aging; 2014 Dec; 35(12):2785-2790. PubMed ID: 24997674
[TBL] [Abstract][Full Text] [Related]
3. APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.
Schiepers OJ; Harris SE; Gow AJ; Pattie A; Brett CE; Starr JM; Deary IJ
Mol Psychiatry; 2012 Mar; 17(3):315-24. PubMed ID: 21263443
[TBL] [Abstract][Full Text] [Related]
4. Systemic markers of inflammation and cognitive decline in old age.
Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG
J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190
[TBL] [Abstract][Full Text] [Related]
5. APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies.
Niti M; Yap KB; Kua EH; Ng TP
J Gerontol A Biol Sci Med Sci; 2009 Feb; 64(2):306-11. PubMed ID: 19181718
[TBL] [Abstract][Full Text] [Related]
6. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
[TBL] [Abstract][Full Text] [Related]
7. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
[TBL] [Abstract][Full Text] [Related]
8. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
9. Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.
Liu X; Beck T; Dhana K; Tangney CC; Desai P; Krueger K; Evans DA; Rajan KB
J Nutr Health Aging; 2024 May; 28(5):100211. PubMed ID: 38507884
[TBL] [Abstract][Full Text] [Related]
10. Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.
Rajan KB; Wilson RS; Skarupski KA; Mendes de Leon CF; Evans DA
Psychosom Med; 2014 Feb; 76(2):101-8. PubMed ID: 24434953
[TBL] [Abstract][Full Text] [Related]
11. Serum inflammatory proteins and cognitive decline in older persons.
Dik MG; Jonker C; Hack CE; Smit JH; Comijs HC; Eikelenboom P
Neurology; 2005 Apr; 64(8):1371-7. PubMed ID: 15851726
[TBL] [Abstract][Full Text] [Related]
12. Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging.
Hu P; Bretsky P; Crimmins EM; Guralnik JM; Reuben DB; Seeman TE
J Gerontol A Biol Sci Med Sci; 2006 Jun; 61(6):616-20. PubMed ID: 16799145
[TBL] [Abstract][Full Text] [Related]
13. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
Whitehair DC; Sherzai A; Emond J; Raman R; Aisen PS; Petersen RC; Fleisher AS;
Alzheimers Dement; 2010 Sep; 6(5):412-9. PubMed ID: 20813342
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
15. Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: a 3-year follow-up study.
Matsushima J; Kawashima T; Nabeta H; Imamura Y; Watanabe I; Mizoguchi Y; Kojima N; Yamada S; Monji A
J Affect Disord; 2015 Mar; 173():9-14. PubMed ID: 25462389
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and neural signatures of the APOE E4 allele in mid-aged adults.
Evans S; Dowell NG; Tabet N; Tofts PS; King SL; Rusted JM
Neurobiol Aging; 2014 Jul; 35(7):1615-23. PubMed ID: 24582638
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants.
Lyall DM; Ward J; Ritchie SJ; Davies G; Cullen B; Celis C; Bailey ME; Anderson J; Evans J; Mckay DF; Mcintosh AM; Sattar N; Smith DJ; Deary IJ; Pell JP
Age Ageing; 2016 Jul; 45(4):511-7. PubMed ID: 27103599
[TBL] [Abstract][Full Text] [Related]
18. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.
Van Gerven PW; Van Boxtel MP; Ausems EE; Bekers O; Jolles J
Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
20. [Apolipoprotein E4 and memory decline in the elderly].
Jonker C; Dik MG; van Kamp GJ; Deeg DJ
Tijdschr Gerontol Geriatr; 2000 Oct; 31(5):198-202. PubMed ID: 11064931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
